Add like
Add dislike
Add to saved papers

Optimizing Electrophysiology Studies to Prevent Sudden Cardiac Death After Myocardial Infarction.

BACKGROUND: This study assessed associations of minimum final extrastimulus coupling interval utilised within electrophysiology study (EPS) after MI and possible site of origin of induced ventricular tachycardia (VT) with long-term occurrence of spontaneous ventricular tachyarrhythmia and longterm survival.

METHODS: This prospective study recruited consecutive patients with LVEF ≤ 40% who underwent EPS day 3-5 after MI between 2004-2017. Positive EPS was defined as sustained monomorphic VT cycle length ≥200 ms for ≥10 seconds, or shorter duration if hemodynamic compromise occurred. Each of the four extrastimuli was shortened by 10 ms at a time, until it failed to capture the ventricle (ventricular refractoriness) or induced ventricular tachyarrhythmia. Outcomes included spontaneous ventricular tachyarrhythmia occurrence and all-cause mortality.

RESULTS: Shorter coupling interval length of final extra-stimulus that induced VT was associated with higher risk of spontaneous ventricular tachyarrhythmia (p < 0.001). Significantly higher rates of spontaneous ventricular tachyarrhythmia (65.2% versus 23.2%; p < 0.001) were observed for final coupling interval at EPS <200 ms versus >200 ms. RBBB morphology of induced VT, with possible site of origin from left ventricle, was associated with all-cause mortality (HR 3.2, p = 0.044) and a composite of spontaneous ventricular tachyarrhythmia recurrence or mortality (HR 1.8, p = 0.043).

CONCLUSIONS: VT induced with shorter coupling intervals were associated with higher risk of spontaneous ventricular tachyarrhythymia on follow-up, indicating that the final extrastimulus coupling interval at EPS early after MI should be determined by ventricular refractoriness. Induced VT with possible origin from left ventricle was associated with increased risk of spontaneous ventricular tachyarrhythmia recurrence or death.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app